Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Hypertrophic pulmonary osteoarthropathy: an unusual presentation.

Kumari P, Yeung P, Medani A, Kiani AN.

Rheumatol Adv Pract. 2018 Jun 20;2(1):rky009. doi: 10.1093/rap/rky009. eCollection 2018.

2.

Serum osteoprotegrin (OPG) in subclinical atherosclerosis in systemic lupus erythematosus.

Kiani AN, Aukrust P, Ueland T, Hollan I, Barr E, Magder LS, Petri M.

Lupus. 2017 Jul;26(8):865-870. doi: 10.1177/0961203316682101. Epub 2016 Dec 6.

3.

Progression of noncalcified and calcified coronary plaque by CT angiography in SLE.

Khan A, Arbab-Zadeh A, Kiani AN, Magder LS, Petri M.

Rheumatol Int. 2017 Jan;37(1):59-65. doi: 10.1007/s00296-016-3615-z. Epub 2016 Nov 23.

4.

Coronary calcification in SLE: comparison with the Multi-Ethnic Study of Atherosclerosis.

Kiani AN, Magder LS, Post WS, Szklo M, Bathon JM, Schreiner PJ, O'Leary D, Petri M.

Rheumatology (Oxford). 2015 Nov;54(11):1976-81. doi: 10.1093/rheumatology/kev198. Epub 2015 Jun 22.

5.

The Role of MicroRNAs and Human Epidermal Growth Factor Receptor 2 in Proliferative Lupus Nephritis.

Costa-Reis P, Russo PA, Zhang Z, Colonna L, Maurer K, Gallucci S, Schulz SW, Kiani AN, Petri M, Sullivan KE.

Arthritis Rheumatol. 2015 Sep;67(9):2415-26. doi: 10.1002/art.39219.

6.

Myocardial T2 mapping by cardiovascular magnetic resonance reveals subclinical myocardial inflammation in patients with systemic lupus erythematosus.

Zhang Y, Corona-Villalobos CP, Kiani AN, Eng J, Kamel IR, Zimmerman SL, Petri M.

Int J Cardiovasc Imaging. 2015 Feb;31(2):389-97. doi: 10.1007/s10554-014-0560-3. Epub 2014 Oct 29.

PMID:
25352245
7.

Apolipoprotein-containing lipoprotein subclasses and subclinical atherosclerosis in systemic lupus erythematosus.

Kiani AN, Fang H, Akhter E, Quiroga C, Simpson N, Alaupovic P, Magder LS, Petri M.

Arthritis Care Res (Hoboken). 2015 Mar;67(3):442-6. doi: 10.1002/acr.22430.

8.

Vitamin D deficiency does not predict progression of coronary artery calcium, carotid intima-media thickness or high-sensitivity C-reactive protein in systemic lupus erythematosus.

Kiani AN, Fang H, Magder LS, Petri M.

Rheumatology (Oxford). 2013 Nov;52(11):2071-6. doi: 10.1093/rheumatology/ket271. Epub 2013 Aug 16.

9.

Predictors of self-reported health-related quality of life in systemic lupus erythematosus.

Kiani AN, Strand V, Fang H, Jaranilla J, Petri M.

Rheumatology (Oxford). 2013 Sep;52(9):1651-7. doi: 10.1093/rheumatology/ket171. Epub 2013 May 16.

10.

Semiquantified noncalcified coronary plaque in systemic lupus erythematosus.

Kiani AN, Vogel-Claussen J, Arbab-Zadeh A, Magder LS, Lima J, Petri M.

J Rheumatol. 2012 Dec;39(12):2286-93. doi: 10.3899/jrheum.120197. Epub 2012 Oct 1. Erratum in: J Rheumatol. 2012 Dec;39(12):2366. Arbab-Zadeh, Armin [added].

11.

Urinary vascular cell adhesion molecule, but not neutrophil gelatinase-associated lipocalin, is associated with lupus nephritis.

Kiani AN, Wu T, Fang H, Zhou XJ, Ahn CW, Magder LS, Mohan C, Petri M.

J Rheumatol. 2012 Jun;39(6):1231-7. doi: 10.3899/jrheum.111470. Epub 2012 Apr 15.

12.

Association of noninvasively measured renal protein biomarkers with histologic features of lupus nephritis.

Brunner HI, Bennett MR, Mina R, Suzuki M, Petri M, Kiani AN, Pendl J, Witte D, Ying J, Rovin BH, Devarajan P.

Arthritis Rheum. 2012 Aug;64(8):2687-97. doi: 10.1002/art.34426.

13.

Predictors of progression in atherosclerosis over 2 years in systemic lupus erythematosus.

Kiani AN, Post WS, Magder LS, Petri M.

Rheumatology (Oxford). 2011 Nov;50(11):2071-9. doi: 10.1093/rheumatology/ker285. Epub 2011 Aug 28.

14.

Mycophenolate mofetil (MMF) does not slow the progression of subclinical atherosclerosis in SLE over 2 years.

Kiani AN, Magder LS, Petri M.

Rheumatol Int. 2012 Sep;32(9):2701-5. doi: 10.1007/s00296-011-2048-y. Epub 2011 Jul 27.

15.

Lupus Atherosclerosis Prevention Study (LAPS).

Petri MA, Kiani AN, Post W, Christopher-Stine L, Magder LS.

Ann Rheum Dis. 2011 May;70(5):760-5. doi: 10.1136/ard.2010.136762. Epub 2010 Dec 21.

PMID:
21177297
16.

Quality-of-life measurements versus disease activity in systemic lupus erythematosus.

Kiani AN, Petri M.

Curr Rheumatol Rep. 2010 Aug;12(4):250-8. doi: 10.1007/s11926-010-0114-1. Review.

PMID:
20586000
17.

Noncalcified coronary plaque in systemic lupus erythematosus.

Kiani AN, Vogel-Claussen J, Magder LS, Petri M.

J Rheumatol. 2010 Mar;37(3):579-84. doi: 10.3899/jrheum.090824. Epub 2010 Jan 28.

PMID:
20110529
18.

Endogenous thrombin potential in the assessment of hypercoagulability in systemic lupus erythematosus.

Mehta BM, Kiani AN, Chen C, Jani J, Kickler TS, Petri M.

Am J Hematol. 2010 Jan;85(1):83-5. doi: 10.1002/ajh.21566. No abstract available.

19.

Urine osteoprotegerin and monocyte chemoattractant protein-1 in lupus nephritis.

Kiani AN, Johnson K, Chen C, Diehl E, Hu H, Vasudevan G, Singh S, Magder LS, Knechtle SJ, Petri M.

J Rheumatol. 2009 Oct;36(10):2224-30. doi: 10.3899/jrheum.081112. Epub 2009 Jul 31.

PMID:
19648301
20.
21.
22.

Aortic valve calcification in systemic lupus erythematosus.

Kiani AN, Fishman EK, Petri M.

Lupus. 2006;15(12):873-6.

PMID:
17211993

Supplemental Content

Loading ...
Support Center